™Your Policy Risk Impact Agent
60 chapters · 1,211 sections in this title.
Mont. Code Ann. § 50-43-101 Purpose
0.3K chars
The purpose of this part is to provide for the continuation of medication initiated by a physician for multiple sclerosis. This medication includes the substances described in this part and has been found to be effective in alleviating the symptoms of multiple sclerosis.
Mont. Code Ann. § 50-43-102 Definitions
0.7K chars
In this part, the following definitions apply: (1) "Calcium-EAP" means a calcium salt of the monoester (2-ethylamine) of phosphoric acid. (2) "Harnosal" means a compound of sulfamethizole and sulfaethidole. A 500-milligram tablet contains 350 milligrams of sulfamethizole and 150 …
Mont. Code Ann. § 50-43-103 Authorization Of Medication
0.2K chars
The manufacture, sale, possession, and distribution of calcium-EAP, harnosal, and phosetamin to provide for the continuation of medication initiated by a physician for multiple sclerosis are lawful within this state.
Mont. Code Ann. § 50-43-104 Health Care Facility May Not Interfere
0.2K chars
A health care facility may not interfere with the physician-patient relationship by restricting or forbidding the use of calcium-EAP, harnosal, or phosetamin when prescribed or administered by a physician.